Australia's Integral Diagnostics hits over 2-year low on weak FY profit

Integral Diagnostics

27/07/2022 02:26

** Shares of Integral Diagnostics  IDX.AX  drop as much as
13.8% to A$2.380, their lowest since April 3, 2020
    ** The medical imaging services firm posts https://www.asx.com.au/asxpdf/20220727/pdf/45c6pfzk5bv59b.pdf
 FY operating net profit after tax of A$21.7 mln ($15.08 mln),
down 43% from a year earlier
    ** Says H2 of FY22 continued to be affected by COVID-19
across geographies in which co operates
    ** IDX reports FY operating revenue of A$316.3 mln, up 5%
from a year ago
    ** Stock set to mark worst day since Aug 27, 2021 if losses
hold
    ** More than 800,000 shares change hands, compared with the
30-day average of about 600,000 shares 
    ** Stock down for third straight day
    ** As of last close, IDX down ~43.4% YTD
    
     ($1 = 1.4391 Australian dollars)

 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))